510(k) K240920

HemoCare Bicarbonate Concentrate Set (BCS) by Deka Research and Development — Product Code KPO

K240920 is an FDA 510(k) premarket notification submitted by Deka Research and Development for the device "HemoCare Bicarbonate Concentrate Set (BCS)". The FDA issued a decision of Substantially Equivalent on July 12, 2024. The device falls under product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)), a Class II device regulated under 21 CFR 876.5820. Deka Research and Development has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 12, 2024
Date Received
April 4, 2024
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Device Class
Class II
Regulation Number
876.5820
Review Panel
GU
Submission Type